Brief: Neoleukin Therapeutics Announces 1-For-4 Reverse Stock Split

Neurogene

15/12/2023 24:06

Dec 14 (Reuters) - Neoleukin Therapeutics Inc  NLTX.O :
    * NEOLEUKIN THERAPEUTICS ANNOUNCES 1-FOR-4 REVERSE STOCK
SPLIT
    * NEOLEUKIN-CO'S COMMON STOCK EXPECTED TO BEGIN TRADING ON
POST-REVERSE STOCK SPLIT BASIS ON NASDAQ GLOBAL MARKET ON DEC
19, UNDER NAME NEUROGENE INC

Source text for Eikon:  ID:nGNX5kKdrY 
Further company coverage:  NLTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))